Journal Basic Info
- Impact Factor: 1.989**
- H-Index: 6
- ISSN: 2637-4625
- DOI: 10.25107/2637-4625
Major Scope
- Urological Surgery
- Reconstructive Surgery
- Surgery & Surgical Research
- Hand Surgery
- Plastic Surgery
- Obstetrics & Gynecology
- Dental Surgery
- Orthopaedic Surgery
Abstract
Citation: World J Surg Surg Res. 2019;2(1):1163.DOI: 10.25107/2637-4625.1163
Shortage in BCG Vaccine Impacts Bladder Cancer Treatment
Michael Harvey and Gregory Jack
Department of Urology, Austin Health, Australia
*Correspondance to: Michael Harvey
PDF Full Text Short Communication | Open Access
Abstract:
Bladder cancer is 8th most common cancer and 11th leading cause of cancer deaths annual. The current gold standard treatment for non-muscle invasive bladder cancer is intravesical BCG vaccine. However, current shortages have necessitated rationing of this life saving medication and affected the treatment of primary bladder cancer with great effect on patients.
Keywords:
Cite the Article:
Harvey M, Jack G. Shortage in BCG Vaccine Impacts Bladder Cancer Treatment. World J Surg Surgical Res. 2019; 2: 1163..